Quick Answer
Rapport Therapeutics, Inc. reported Total Assets of $512.43 million for fiscal year 2025.
Rapport Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $512.43M | +62.7% |
| 2024 | $314.93M | +102.6% |
| 2023 | $155.42M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $535.32M | +61.7% | +87.5% |
| June 30, 2025 | $285.50M | -17.5% | -5.5% |
| March 31, 2025 | $302.05M | — | -4.1% |
| December 31, 2024 | $314.93M | +102.6% | -4.9% |
| September 30, 2024 | $331.14M | — | -4.3% |
| June 30, 2024 | $346.10M | — | +122.7% |
| December 31, 2023 | $155.42M | — | — |
- Rapport Therapeutics, Inc. showed an increase of +62.7% in Total Assets compared to the prior fiscal year.
- Over the 2023–2025 period, Rapport Therapeutics, Inc.’s total assets has grown by 229.7% (from $155.42 million to $512.43 million).
- The most recent figure is from Rapport Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: